Investment Management Associates’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-21,413
Closed -$620K 33
2024
Q3
$620K Buy
21,413
+3,140
+17% +$91.6K 0.24% 24
2024
Q2
$511K Sell
18,273
-1,596
-8% -$43.9K 0.18% 27
2024
Q1
$551K Hold
19,869
0.19% 29
2023
Q4
$572K Sell
19,869
-6,789
-25% -$205K 0.22% 29
2023
Q3
$884K Sell
26,658
-187
-0.7% -$6.61K 0.37% 28
2023
Q2
$985K Buy
26,845
+422
+2% +$16.4K 0.36% 31
2023
Q1
$1.08M Buy
26,423
+364
+1% +$15.7K 0.44% 30
2022
Q4
$1.34M Buy
26,059
+1,789
+7% +$85.8K 0.56% 30
2022
Q3
$1.06M Sell
24,270
-419
-2% -$20.4K 0.5% 31
2022
Q2
$1.25M Hold
24,689
0.54% 29
2022
Q1
$1.28M Sell
24,689
-906
-4% -$47K 0.57% 31
2021
Q4
$1.51M Hold
25,595
0.69% 32
2021
Q3
$1.1M Buy
25,595
+236
+0.9% +$10.5K 0.57% 34
2021
Q2
$993K Buy
25,359
+1,429
+6% +$55.6K 0.52% 35
2021
Q1
$867K Buy
23,930
+14,294
+148% +$508K 0.51% 40
2020
Q4
$355K Buy
+9,636
New +$353K 0.27% 45

Other funds holding PFE

Investment Management Associates's PFE Position: Q4 2024 in Review

Investment Management Associates sold out of Pfizer (PFE) in Q4 2024, closing a stake of 21,413 shares — an estimated $620K sold.

Investment Management Associates first reported a position in PFE in Q4 2020 and held it in 16 quarters. The position peaked at $1.51M in Q4 2021. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Investment Management Associates reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Investment Management Associates sold 21,413 Pfizer shares in Q4 2024, an estimated $620K.
  • Investment Management Associates first reported a position in Pfizer in Q4 2020 and held it in 16 quarters.
  • Investment Management Associates's Pfizer position peaked at $1.51M in Q4 2021.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Investment Management Associates's 13F filing for Q4 2024, filed 3 Feb 2025.